phenobarbital has been researched along with Anemia, Cooley's in 1 studies
Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clinically apparent jaundice is unusual in patients with beta-thalassemia major." | 1.36 | Persistent jaundice in an infant with homozygous beta thalassemia due to co-inherited Crigler-Najjar syndrome. ( Aggarwal, V; Aneja, S; Fabiano, C; Sammarco, P; Seth, A; Sharma, S, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aggarwal, V | 1 |
| Seth, A | 1 |
| Sharma, S | 1 |
| Aneja, S | 1 |
| Sammarco, P | 1 |
| Fabiano, C | 1 |
1 other study available for phenobarbital and Anemia, Cooley's
| Article | Year |
|---|---|
Persistent jaundice in an infant with homozygous beta thalassemia due to co-inherited Crigler-Najjar syndrome.
Topics: beta-Thalassemia; Crigler-Najjar Syndrome; Erythrocyte Transfusion; Fatal Outcome; GABA Modulators; | 2010 |